Modulation of peripheral sensory neurons by the immune system: Implications for pain therapy

Pharmacological Reviews

Volumn 63, Issue 4, 2011, Pages 860-881

  Stein, Christoph ^a   Machelska, Halina ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ASIMADOLINE; CANNABINOID RECEPTOR; CHEMOKINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DELTA OPIATE RECEPTOR AGONIST; ENDOCANNABINOID; KAPPA OPIATE RECEPTOR AGONIST; LOPERAMIDE; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NORADRENALIN; OPIATE; OPIATE AGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; SERINE PROTEINASE;

ADDICTION; ALLODYNIA; ANTINOCICEPTION; ARTICLE; CANCER PAIN; CELL MIGRATION; CHRONIC PAIN; COGNITIVE DEFECT; DRUG ANTAGONISM; DRUG BINDING; DRUG MECHANISM; DRUG TOLERANCE; GASTROINTESTINAL HEMORRHAGE; GENE EXPRESSION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; NERVE CELL PLASTICITY; NERVE INJURY; NEUROMODULATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PAIN ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SEDATION; SENSORY NERVE CELL; SIDE EFFECT; SIGNAL TRANSDUCTION; THROMBOEMBOLISM; WOUND HEALING;

HUMANS; IMMUNE SYSTEM; INFLAMMATION; PAIN; PAIN MANAGEMENT; RECEPTORS, OPIOID; SENSORY RECEPTOR CELLS;

EID: 80053606300     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.110.003145     Document Type: Article

References (332)

1. Abram SE, Yi J, Fuchs A, and Hogan QH (2006) Permeability of injured and intact peripheral nerves and dorsal root ganglia. Anesthesiology 105:146-153.
2. Acosta CG and López HS (1999) delta opioid receptor modulation of several voltagedependent Ca(2+) currents in rat sensory neurons. J Neurosci 19:8337-8348.
3. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870-879.
4. Ahluwalia J, Urban L, Bevan S, and Nagy I (2003) Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17:2611-2618.
5. Akins PT and McCleskey EW (1993) Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 56:759-769.
6. Akopian AN, Ruparel NB, Jeske NA, Patwardhan A, and Hargreaves KM (2009) Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol Sci 30:79-84.
7. Aley KO and Levine JD (2002) Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111:389-397.
8. American Society of Anesthesiologists Task Force on Acute Pain Management (2004) Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 100:1573-1581.
9. Anand P, Whiteside G, Fowler CJ, and Hohmann AG (2009) Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 60:255-266.
10. Andreev N, Urban L, and Dray A (1994) Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience 58:793-798.
11. Ansah OB and Pertovaara A (2007) Peripheral suppression of arthritic pain by intraarticular fadolmidine, an alpha 2-adrenoceptor agonist, in the rat. Anesth Analg 105:245-250.
12. Antonijevic I, Mousa SA, Schäfer M and Stein C (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165-172.
13. Austin PJ and Moalem-Taylor G (2010) The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 229:26-50.
14. Azad SC, Beyer A, Römer AW, Galle-Röd A, Peter K, and Schöps P (2000) Continuous axillary brachial plexus analgesia with low dose morphine in patients with complex regional pain syndromes. Eur J Anaesthesiol 17:185-188.
15. Baamonde A, Lastra A, Juárez L, García-Suárez O, Meana A, Hidalgo A, and Menéndez L (2006) Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma. Peptides 27:2778-2785.
16. Ballet S, Conrath M, Fischer J, Kaneko T, Hamon M, and Cesselin F (2003) Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats. Neuropeptides 37:211-219.
17. Bao L, Jin SX, Zhang C, Wang LH, Xu ZZ, Zhang FX, Wang LC, Ning FS, Cai HJ, Guan JS, et al. (2003) Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 37:121-133.
18. Barthó L, Stein C, and Herz A (1990) Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation. Naunyn Schmiedebergs Arch Pharmacol 342:666-670.
19. Beland B and Fitzgerald M (2001) Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats. Pain 90:143-150.
20. Belkowski SM, Alicea C, Eisenstein TK, Adler MW, and Rogers TJ (1995) Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. J Pharmacol Exp Ther 273:1491-1496.
21. Benedetti F, Arduino C, and Amanzio M (1999) Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 19:3639-3648.
22. Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, and Clarke WP (2007a) Rapid modulation of mu-opioid receptor signaling in primary sensory neurons. J Pharmacol Exp Ther 321:839-847.
23. Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, and Milam SB (2007b) Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144:889-897.
24. Beutler AS, Banck MS, Walsh CE, and Milligan ED (2005) Intrathecal gene transfer by adeno-associated virus for pain. Curr Opin Mol Ther 7:431-439.
25. Bigliardi PL, Büchner S, Rufli T, and Bigliardi-Qi M (2002) Specific stimulation of migration of human keratinocytes by mu-opiate receptor agonists. J Recept Signal Transduct Res 22:191-199.
26. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, and Bigliardi-Qi M(2009) Opioids and the skin-where do we stand? Exp Dermatol 18:424-430.
27. Binder W, Carmody J, and Walker J (2000) Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. J Pharmacol Exp Ther 292:303-309.
28. Binder W, Machelska H, Mousa S, Schmitt T, Riviere PJ, Junien JL, Stein C, and Schäfer M (2001) Analgesic and antiinflammatory effects of two novel kappaopioid peptides. Anesthesiology 94:1034-1044.
29. Binder W, Mousa SA, Sitte N, Kaiser M, Stein C, and Schäfer M (2004) Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur J Neurosci 20:92-100.
30. Bisogno T, Maurelli S, Melck D, De Petrocellis L, and Di Marzo V (1997) Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272:3315-3323.
31. Blätke MA, Meyer S, Stein C, and Marwan W (2010) Petri Net modeling via a modular and hierarchical approach applied to nociception, in International Workshop on Biological Processes & Petri Nets (Chaouiya C and Heiner M eds) pp 131-143; 2010 Jun 21-25, Braga, Portugal.
32. Bong GW, Rosengren S, and Firestein GS (1996) Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of Nmethyl-D-aspartate receptors. J Clin Invest 98:2779-2785.
33. Börzsei R, Pozsgai G, Bagoly T, Elekes K, Pintér E, Szolcsányi J, and Helyes Z (2008) Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 152:82-88.
34. Brack A, Labuz D, Schiltz A, Rittner HL, Machelska H, Schäfer M, Reszka R, and Stein C (2004a) Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 101:204-211.
35. Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schäfer M, and Stein C (2004b) Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100:149-157.
36. Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, Schäfer M and Stein C (2004c) Control of inflammatory pain by chemokine-mediated recruitment of opioid- containing polymorphonuclear cells. Pain 112:229-238.
37. Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, Labuz D, Zöllner C, Schäfer M, and Stein C (2004d) Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108:67-75.
38. Brandsson S, Karlsson J, Morberg P, Rydgren B, Eriksson BI, and Hedner T (2000) Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patients. Acta Orthop Scand 71:280-285.
39. Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M, and Pohl M (2001) Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 21:7881-7888.
40. Busch-Dienstfertig M and Stein C (2010) Opioid receptors and opioid peptideproducing leukocytes in inflammatory pain-basic and therapeutic aspects. Brain Behav Immun 24:683-694.
41. Buzzetti R, McLoughlin L, Lavender PM, Clark AJ, and Rees LH (1989) Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormonelike immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83:733-737.
42. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, and Stein C (1997) Immune cell-derived κ-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100:142-148.
43. Cabot PJ, Carter L, Schäfer M, and Stein C (2001) Methionine-enkephalin- and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93:207-212.
44. Calza L, Pozza M, Zanni M, Manzini CU, Manzini E, and Hökfelt T (1998) Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82:575-589.
45. Catheline G, Guilbaud G, and Kayser V (1998) Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats. Eur J Pharmacol 357:171-178.
46. Chadzinska M, Maj M, Scislowska-Czarnecka A, Przewłocka B, and Plytycz B (2001) Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss mice. Pol J Pharmacol 53:715-718.
47. Chadzinska M, Starowicz K, Scislowska-Czarnecka A, Bilecki W, Pierzchala-Koziec K, Przewlocki R, Przewlocka B, and Plytycz B (2005) Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. Immunol Lett 101:185-192.
48. Chen CL, Broom DC, Liu Y, de Nooij JC, Li Z, Cen C, Samad OA, Jessell TM, Woolf CJ, and Ma Q (2006) Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron 49:365-377.
49. Chen YL, Law PY, and Loh HH (2008) The other side of the opioid story: modulation of cell growth and survival signaling. Curr Med Chem 15:772-778.
50. Chizhmakov I, Yudin Y, Mamenko N, Prudnikov I, Tamarova Z, and Krishtal O (2005) Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism. Neuropharmacology 48:639-647.
51. Cho CH, Wu KK, Wu S, Wong TM, So WH, Liu ES, Chu KM, Shin VY, Ye YN, and Wong BC (2003) Morphine as a drug for stress ulcer prevention and healing in the stomach. Eur J Pharmacol 460:177-182.
52. Chu GH, Gu M, Cassel JA, Belanger S, Graczyk TM, DeHaven RN, Conway-James N, Koblish M, Little PJ, DeHaven-Hudkins DL, et al. (2007) Novel malonamide derivatives as potent kappa opioid receptor agonists. Bioorg Med Chem Lett 17:1951-1955.
53. Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A, Tontini A, Sanchini S, Sciolino NR, Spradley JM, et al. (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13: 1265-1270.
54. Clark AJ, Lavender PM, Coates P, Johnson MR, and Rees LH (1990) In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol Endocrinol 4:1737-1743.
55. Coggeshall RE, Zhou S, and Carlton SM (1997) Opiate receptors on peripheral sensory axons. Brain Res 764:126-132.
56. Cool DR and Loh YP (1994) Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin. Biochimie 76:265-270.
57. Craft RM, Henley SR, Haaseth RC, Hruby VJ, and Porreca F (1995) Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther 275:1535-1542.
58. Cunha FQ and Ferreira SH (2003) Peripheral hyperalgesic cytokines. Adv Exp Med Biol 521:22-39.
59. Cunha TM, Roman-Campos D, Lotufo CM, Duarte HL, Souza GR, Verri WA, Jr., Funez MI, Dias QM, Schivo IR, Domingues AC, Sachs D, Chiavegatto S, Teixeira MM, Hothersall JS, Cruz JS, Cunha FQ, and Ferreira SH (2010) Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci USA 107:4442-4447.
60. Day TK, Pepper WT, Tobias TA, Flynn MF, and Clarke KM (1995) Comparison of intra-articular and epidural morphine for analgesia following stifle arthrotomy in dogs. Vet Surg 24:522-530.
61. DeHaven-Hudkins DL and Dolle RE (2004) Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Des 10:743-757.
62. De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, and Di Marzo V (2008) Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther 325:1007-1015.
63. Di Marzo V (2009) The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60:77-84.
64. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, and Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264:258-267.
65. Dionne RA, Lepinski AM, Gordon SM, Jaber L, Brahim JS, and Hargreaves KM (2001) Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 70:66-73.
66. Donnerer J, Schuligoi R, and Stein C (1992) Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49:693-698.
67. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60:1524-1534.
68. Eiden LE (1987) The enkephalin-containing cell: strategies for polypeptide synthesis and secretion throughout the neuroendocrine system. Cell Mol Neurobiol 7:339-352.
69. Eisenach JC, Carpenter R, and Curry R (2003) Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis. Pain 101:89-95.
70. Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A, Schäfer M, Stein C, and Zöllner C (2007) Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 71:12-18.
71. Faktorovich EG and Basbaum AI (2010) Effect of topical 0.5% morphine on postoperative pain after photorefractive keratectomy. J Refract Surg 26:934-941.
72. Farquhar-Smith WP and Rice AS (2003) A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology 99:1391-1401.
73. Fichna J, Janecka A, Costentin J, and Do Rego JC (2007) The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59:88-123.
74. Fischbach T, Greffrath W, Nawrath H, and Treede RD (2007) Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. J Neurophysiol 98:929-938.
75. Fromont A, De Seze J, Fleury MC, Maillefert JF, and Moreau T (2009) Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine 45:55-57.
76. Fürst S, Riba P, Friedmann T, Tímar J, Al-Khrasani M, Obara I, Makuch W, Spetea M, Schütz J, Przewlocki R, et al. (2005) Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J Pharmacol Exp Ther 312:609-618.
77. Gauldie SD, McQueen DS, Pertwee R, and Chessell IP (2001) Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br J Pharmacol 132:617-621.
78. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, et al. (2011) Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152:1238-1248.
79. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T, and Beaudet A (2006) Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26:953-962.
80. + current in rat sensory neurons in vitro. Neuroscience Lett 212:83-86.
81. Gross ER, Hsu AK, and Gross GJ (2009) Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion. Anesth Analg 109:1395-1402.
82. Guan Y, Johanek LM, Hartke TV, Shim B, Tao YX, Ringkamp M, Meyer RA, and Raja SN (2008) Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 138:318-329.
83. Guindon J and Beaulieu P (2009) The role of the endogenous cannabinoid system in peripheral analgesia. Curr Mol Pharmacol 2:134-139.
84. Guindon J and Hohmann AG (2009) The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8:403-421.
85. Gupta A, Bodin L, Holmström B, and Berggren L (2001) A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 93:761-770.
86. Hanna MH, Elliott KM, and Fung M (2005) Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery. Anesthesiology 102:815-821.
87. Hao S, Mata M, Glorioso JC, and Fink DJ (2006) HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain 2:6.
88. Hassan AH, Ableitner A, Stein C, and Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185-195.
89. 2+ channels by G-protein beta gamma subunits. Nature 380: 258-262.
90. Hermanussen S, Do M, and Cabot PJ (2004) Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immunederived antinociception: reversible by donor activated lymphocytes. Anesth Analg 98:723-729.
91. Heurich M, Mousa SA, Lenzner M, Morciniec P, Kopf A, Welte M, and Stein C (2007) Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds. Brain Behav Immun 21:544-552.
92. Hook S, Camberis M, Prout M, Konig M, Zimmer A, Van Heeke G, and Le Gros G (1999) Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro. Immunol Cell Biol 77:385-390.
93. Hua S, Hermanussen S, Tang L, Monteith GR, and Cabot PJ (2006) The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons. Anesth Analg 103:1558-1564.
94. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, and Malan TP, Jr. (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093-3098.
95. Inglis JJ, McNamee KE, Chia SL, Essex D, Feldmann M, Williams RO, Hunt SP, and Vincent T (2008) Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 58:3110-3119.
96. Ingram SL and Williams JT (1994) Opioid inhibition of Ih via adenylyl cyclase. Neuron 13:179-186.
97. Jaber L, Swaim WD, and Dionne RA (2003) Immunohistochemical localization of mu-opioid receptors in human dental pulp. J Endod 29:108-110.
98. Jaureguito JW, Wilcox JF, Thisted RA, Phillips C, Cunningham B, and Reider B (2002) The effects of morphine on human articular cartilage of the knee: an in vitro study. Arthroscopy 18:631-636.
99. Jeanjean AP, Moussaoui SM, Maloteaux JM, and Laduron PM (1995) Interleukin-1βinduces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 68:151-157.
100. Ji RR, Zhang Q, Law PY, Low HH, Elde R, and Hökfelt T (1995) Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
101. Jiménez N, Puig MM, and Pol O (2006) Antiexudative effects of opioids and xpression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide. J Pharmacol Exp Ther 316:261-270.
102. Jin S, Lei L, Wang Y, Da D, and Zhao Z (1999) Endomorphin-1 reduces arrageenaninduced fos expression in the rat spinal dorsal horn. Neuropeptides 33:281-284.
103. Joshi JB and Dave HP (1992) Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I. Proc Natl Acad Sci USA 89:1006-1010.
104. Junger H, Moore AC, and Sorkin LS (2002) Effects of full-thickness burns on nociceptor sensitization in anesthetized rats. Burns 28:772-777.
105. Kabli N and Cahill CM (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127:84-93.
106. Kager I, Mousa SA, Sieper J, Stein C, Pipam W, and Likar R (2010) Blockade of intra-articular adrenergic receptors increases analgesic demands for pain relief after knee surgery. Rheumatol Int doi:10.1007/s00296-010-1489-z.
107. Kalso E, Smith L, McQuay HJ, and Andrew Moore R (2002) No pain, no gain: clinical excellence and scientific rigour-lessons learned from IA morphine. Pain 98:269-275.
108. Kamphuis S, Kavelaars A, Brooimans R, Kuis W, Zegers BJ, and Heijnen CJ (1997) T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J Neuroimmunol 79:91-99.
109. Kavelaars A, Ballieux RE, and Heijnen CJ (1990) In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 126:3028-3032.
110. Kayser V, Lee SH, and Guilbaud G (1995) Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy. Neuroscience 64:537-545.
111. Keïta H, Kayser V, and Guilbaud G (1995) Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur J Pharmacol 277:275-280.
112. Khalil Z, Sanderson K, Modig M, and Nyberg F (1999) Modulation of peripheral inflammation by locally administered endomorphin-1. Inflamm Res 48:550-556.
113. Khasabova IA, Harding-Rose C, Simone DA, and Seybold VS (2004) Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J Neurosci 24:1744-1753.
114. Khodorova A, Navarro B, Jouaville LS, Murphy JE, Rice FL, Mazurkiewicz JE, Long-Woodward D, Stoffel M, Strichartz GR, Yukhananov R, et al. (2003) Endothelin- B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med 9:1055-1061.
115. Khoury GF, Chen AC, Garland DE, and Stein C (1992) Intraarticular morphine, bupivacaine, and morphine/bupivacaine for pain control after knee videoarthroscopy. Anesthesiology 77:263-266.
116. Kieffer BL and Evans CJ (2009) Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 56 (Suppl 1):205-212.
117. Koch T and Höllt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117:199-206.
118. Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, and Höllt V (2005) Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 67:280-287.
119. Kohno T, Ji RR, Ito N, Allchorne AJ, Befort K, Karchewski LA, and Woolf CJ (2005) Peripheral axonal injury results in reduced mu opioid receptor pre- and postsynaptic action in the spinal cord. Pain 117:77-87.
120. Kolesnikov Y, El-Maarouf A, El-Maarouf Abderrahman A, Rutishauser U, Rutinhauser U, and Pasternak G (2007) Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia. Eur J Pharmacol 568:124-133.
121. Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, and Yaksh TL (2005) Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25:3651-3660.
122. Kopf A, Schmidt S, and Stein C (2006) Topical administration of analgesics, in Textbook of Palliative Medicine (Bruera E, Higginson IJ, Ripamonti C, and von Gunten CF eds) pp 450-457, Hodder Arnold, London.
123. Kraus J (2009) Regulation of mu-opioid receptors by cytokines. Front Biosci (Schol Ed) 1:164-170.
124. Kress M and Kuner R (2009) Mode of action of cannabinoids on nociceptive nerve endings. Exp Brain Res 196:79-88.
125. Küchler S, Wolf NB, Heilmann S, Weindl G, Helfmann J, Yahya MM, Stein C, and Schäfer-Korting M (2010) 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol 148:24-30.
126. Kyrkanides S, Fiorentino PM, Miller JN, Gan Y, Lai YC, Shaftel SS, Puzas JE, Piancino MG, O'Banion MK, and Tallents RH (2007) Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. Arthritis Rheum 56:2038-2048.
127. Labuz D, Berger S, Mousa SA, Zöllner C, Rittner HL, Shaqura MA, Segovia-Silvestre T, Przewlocka B, Stein C, and Machelska H (2006) Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 26:4350-4358.
128. Labuz D, Mousa SA, Schäfer M, Stein C, and Machelska H (2007) Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 1160:30-38.
129. Labuz D, Schmidt Y, Schreiter A, Rittner HL, Mousa SA, and Machelska H (2009) Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest 119:278-286.
130. Labuz D, Schreiter A, Schmidt Y, Brack A, and Machelska H (2010) T lymphocytes containing beta-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun 24:1045-1053.
131. LaMendola J, Martin SK, and Steiner DF (1997) Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies. FEBS Lett 404:19-22.
132. Lang LJ, Pierer M, Stein C, and Baerwald C (2010) Opioids in rheumatic diseases. Ann N Y Acad Sci 1193:111-116.
133. Lawrence AJ, Joshi GP, Michalkiewicz A, Blunnie WP, and Moriarty DC (1992) Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue. Eur J Clin Pharmacol 43:351-355.
134. LeBon B, Zeppetella G, and Higginson IJ (2009) Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage 37:913-917.
135. Lever IJ, Robinson M, Cibelli M, Paule C, Santha P, Yee L, Hunt SP, Cravatt BF, Elphick MR, Nagy I, et al. (2009) Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J Neurosci 29:3766-3780.
136. Lewanowitsch T and Irvine RJ (2002) Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur J Pharmacol 445: 61-67.
137. Ley K, Laudanna C, Cybulsky MI, and Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678-689.
138. Li JL, Kaneko T, and Mizuno N (1996) Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 214:91-94.
139. Likar R, Kapral S, Steinkellner H, Stein C, and Schäfer M (1999) Dose-dependency of intra-articular morphine analgesia. Br J Anaesth 83:241-244.
140. Likar R, Mousa SA, Philippitsch G, Steinkellner H, Koppert W, Stein C, and Schäfer M (2004) Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. Br J Anaesth 93:375-380.
141. Likar R, Mousa SA, Steinkellner H, Koppert W, Philippitsch G, Stein C, and Schäfer M (2007) Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin J Pain 23:136-142.
142. Likar R, Schäfer M, Paulak F, Sittl R, Pipam W, Schalk H, Geissler D, and Bernatzky G (1997) Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 84:1313-1317.
143. Lindegaard C, Frost AB, Thomsen MH, Larsen C, Hansen SH, and Andersen PH (2010a) Pharmacokinetics of intra-articular morphine in horses with lipopolysaccharide-induced synovitis. Vet Anaesth Analg 37:186-195.
144. Lindegaard C, Gleerup KB, Thomsen MH, Martinussen T, Jacobsen S, and Andersen PH (2010b) Anti-inflammatory effects of intra-articular administration of morphine in horses with experimentally induced synovitis. Am J Vet Res 71:69-75.
145. Linner KM, Beyer HS, and Sharp BM (1991) Induction of the messenger ribonucleic acid for proenkephalin A in cultured murine CD4-positive thymocytes. Endocrinology 128:717-724.
146. Linner KM, Quist HE, and Sharp BM (1996) Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology 137: 857-863.
147. Liu J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, Gao B, and Kunos G (2003) Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J Biol Chem 278:45034-45039.
148. Lolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith AI, and Funder JW (1986) Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta-endorphin in spleen macrophages. J Clin Invest 77:1776-1779.
149. Lüscher C and Slesinger PA (2010) Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11:301-315.
150. Lyons PD and Blalock JE (1997) Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 78:47-56.
151. Machelska H (2011a) Dual peripheral actions of immune cells in neuropathic pain. Arch Immunol Ther Exp (Warsz) 59:11-24.
152. Machelska H (2011b) Control of neuropathic pain by immune cells and opioids. CNS Neurol Disord Drug Targets 10:559-570.
153. Machelska H, Brack A, Mousa SA, Schopohl JK, Rittner HL, Schäfer M, and Stein C (2004) Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br J Pharmacol 142:772-780.
154. Machelska H, Cabot PJ, Mousa SA, Zhang Q, and Stein C (1998) Pain control in inflammation governed by selectins. Nat Med 4:1425-1428.
155. Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schafer M, and Stein C (2002) Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 22:5588-5596.
156. Machelska H, Pflüger M, Weber W, Piranvisseh-Völk M, Daubert JD, Dehaven R, and Stein C (1999) Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 290:354-361.
157. Machelska H, Schopohl JK, Mousa SA, Labuz D, Schäfer M, and Stein C (2003) Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 141:30-39.
158. Machelska H, Schroff M, Oswald D, Binder W, Sitte N, Mousa SA, Rittner HL, Brack A, Labuz D, Busch M, et al. (2009) Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain. Mol Pain 5:72.
159. Maldonado R, Valverde O, Turcaud S, Fournié-Zaluski MC, and Roques BP (1994) Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation. Pain 58:77-83.
160. Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, and Urso D (2008) Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther 28:239-249.
161. Martin L, Augé C, Boué J, Buresi MC, Chapman K, Asfaha S, Andrade-Gordon P, Steinhoff M, Cenac N, Dietrich G, et al. (2009) Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 146:121-129.
162. Martinez V, Christensen D, and Kayser V (2002) The glycine/NMDA receptor ntagonist (_)-HA966 enhances the peripheral effect of morphine in neuropathic rats. Pain 99:537-545.
163. Martin-Schild S, Gerall AA, Kastin AJ, and Zadina JE (1998) Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 19:1783-1789.
164. Mata M, Glorioso JC, and Fink DJ (2002) Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol Behav 77:483-488.
165. McDougall JJ (2011) Peripheral analgesia: Hitting pain where it hurts. Biochim Biophys Acta 1812:459-467.
166. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, and Byrne MC (2002) CD4(+)CD25+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311-323.
167. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, and O'Donnell D (2003) Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465:349-360.
168. Menzaghi F, O'Connor SJ, Labissiere G, Gardell LR, Spencer RH, and Chalmers DT (2010) Analgesic and morphine-sparing effects of the kappa opioid agonist CR845 after single iv administration in women undergoing laparoscopic-assisted hysterectomy, in 13th World Congress on Pain pp PT 372; Montreal, Quebec, Canada; 2010 Aug 29-Sep 2. International Association for the Study of Pain, Seattle, WA.
169. Meunier A, Latrémoliere A, Mauborgne A, Bourgoin S, Kayser V, Cesselin F, Hamon M, and Pohl M (2005) Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Mol Ther 11:608-616.
170. Moalem G and Tracey DJ (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51:240-264.
171. Moalem G, Xu K, and Yu L (2004) T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 129:767-777.
172. Moore CA, Milano SK, and Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69:451-482.
173. Mousa SA, Bopaiah CP, Stein C, and Schäfer M (2003) Involvement of corticotropinreleasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106:297-307.
174. Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, and Schäfer M (2007a) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130:502-513.
175. Mousa SA, Machelska H, Schäfer M, and Stein C (2000) Co-expression of betaendorphin with adhesion molecules in a model of inflammatory pain. J Neuroimmunol 108:160-170.
176. Mousa SA, Machelska H, Schäfer M, and Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5-15.
177. Mousa SA, Schäfer M, Mitchell WM, Hassan AH, and Stein C (1996) Local upregulation of corticotropin- releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 311:221-231.
178. Mousa SA, Shakibaei M, Sitte N, Schäfer M, and Stein C (2004) Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145:1331-1341.
179. Mousa SA, Straub RH, Schäfer M, and Stein C (2007b) Beta-endorphin, Metenkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 66:871-879.
180. Mousa SA, Zhang Q, Sitte N, Ji R, and Stein C (2001) beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-78.
181. Nagy P, Kettle AJ, and Winterbourn CC (2010) Neutrophil-mediated oxidation of enkephalins via myeloperoxidase-dependent addition of superoxide. Free Radic Biol Med 49:792-799.
182. Nandi R, Beacham D, Middleton J, Koltzenburg M, Howard RF, and Fitzgerald M (2004) The functional expression of mu opioid receptors on sensory neurons is developmentally regulated; morphine analgesia is less selective in the neonate. Pain 111:38-50.
183. Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG, and Katona I (2009) Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur J Neurosci 29:1964-1978.
184. Obara I, Gunduz Cinar O, Starowicz K, Benyhe S, Borsodi A, and Przewlocka B (2010) Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats. J Neural Transm 117: 421-429.
185. Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, and Przewlocka B (2007) Local peripheral antinociceptive effects of 14-O-ethyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 558:60-67.
186. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, and Przewlocki R (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141:283-291.
187. Obara I, Przewlocki R, and Przewlocka B (2004) Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 360:85-89.
188. Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, and Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027-5035.
189. Ohta K, Shichiri M, Kameya T, Matsubara O, Imai T, Marumo F, and Hirata Y (2000) Thymic hyperplasia as a source of ectopic ACTH production. Endocr J 47:487-492.
190. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, and Hargreaves KM (2005) Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25:8825-8832.
191. Perkins NM and Tracey DJ (2000) Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience 101:745-757.
192. Perrot S, Guilbaud G, and Kayser V (1999) Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation. Pain 83:249-257.
193. Pertovaara A and Wei H (2001) Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. Eur J Pharmacol 429:139-145.
194. Pestonjamasp VK and Burstein SH (1998) Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta 1394:249-260.
195. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoï-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, and Desreumaux P (2003) Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 111:1329-1338.
196. Picard PR, Tramer MR, McQuay HJ, and Moore RA (1997) Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 72:309-318.
197. Pierce TL, Grahek MD, and Wessendorf MW (1998) Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9:385-389.
198. Pohl M, Collin E, Bourgoin S, Conrath M, Benoliel JJ, Nevo I, Hamon M, Giraud P, and Cesselin F (1994) Expression of preproenkephalin A gene and presence of Met-enkephalin in dorsal root ganglia of the adult rat. J Neurochem 63:1226-1234.
199. Pohl M, Meunier A, Hamon M, and Braz J (2003) Gene therapy of chronic pain. Curr Gene Ther 3:223-238.
200. Pol O, Murtra P, Caracuel L, Valverde O, Puig MM, and Maldonado R (2006) Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Neuropharmacology 50:123-132.
201. Polydefkis M, Griffin JW, and McArthur J (2003) New insights into diabetic polyneuropathy. JAMA 290:1371-1376.
202. Poonawala T, Levay-Young BK, Hebbel RP, and Gupta K (2005) Opioids heal ischemic wounds in the rat. Wound Repair Regen 13:165-174.
203. Przewłocki R, Hassan AH, Lason W, Epplen C, Herz A, and Stein C (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48:491-500.
204. Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, and Schäfer M (2006) Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation. Neuroscience 141:989-998.
205. Puehler W, Zöllner C, Brack A, Shaqura MA, Krause H, Schäfer M, and Stein C (2004) Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129:473-479.
206. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, and Flores CM (2008) TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28:6231-6238.
207. Raap T, Jüsten HP, Miller LE, Cutolo M, Schölmerich J, and Straub RH (2000) Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J Rheumatol 27:2558-2565.
208. Ramabadran K (1982) Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice. Life Sci 31:1253-1256.
209. Ramabadran K, Suaudeau C, and Jacob JJ (1982) A comparison of some pharmacological effects of naloxone and N-methylnaloxone in mice. Can J Physiol Pharmacol 60:715-719.
210. Rasenick MM and Childers SR (1989) Modification of Gs-stimulated adenylate cyclase in brain membranes by low pH pretreatment: correlation with altered guanine nucleotide exchange. J Neurochem 53:219-225.
211. Rashid MH, Inoue M, Toda K, and Ueda H (2004) Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther 309:380-387.
212. Rattner A, Korner M, Rosen H, Baeuerle PA, and Citri Y (1991) Nuclear factor kappa B activates proenkephalin transcription in T lymphocytes. Mol Cell Biol 11:1017-1022.
213. Reichert JA, Daughters RS, Rivard R, and Simone DA (2001) Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89:221-227.
214. Richardson MD, Bjorksten AR, Hart JA, and McCullough K (1997) The efficacy of intra-articular morphine for postoperative knee arthroscopy analgesia. Arthroscopy 13:584-589.
215. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schäfer M, and Stein C (2001) Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95:500-508.
216. Rittner HL, Hackel D, Voigt P, Mousa S, Stolz A, Labuz D, Schäfer M, Schaefer M, Stein C, and Brack A (2009a) Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog 5:e1000362.
217. Rittner HL, Hackel D, Yamdeu RS, Mousa SA, Stein C, Schäfer M, and Brack A (2009b) Antinociception by neutrophil-derived opioid peptides in noninflamed tissue-role of hypertonicity and the perineurium. Brain Behav Immun 23:548-557.
218. Rittner HL, Labuz D, Richter JF, Brack A, Schäfer M, Stein C, and Mousa SA (2007a) CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav Immun 21:1021-1032.
219. Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schäfer M, Stein C, and Brack A (2006a) Pain control by CXCR2 ligands through Ca2_-regulated release of opioid peptides from polymorphonuclear cells. FASEB J 20:2627-2629.
220. Rittner HL, Lux C, Labuz D, Mousa SA, Schäfer M, Stein C, and Brack A (2007b) Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology 107:1009-1017.
221. Rittner HL, Machelska H, and Stein C (2008) Immune system, pain and analgesia, in The Senses: A Comprehensive Reference (Basbaum AI, Kaneko A, Shepherd GA, and Westheimer G eds) pp 407-428, Academic Press, San Diego.
222. Rittner HL, Mousa SA, Labuz D, Beschmann K, Schäfer M, Stein C, and Brack A (2006b) Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J Leukoc Biol 79:1022-1032.
223. Romero A, Planas E, Poveda R, Sánchez S, Pol O, and Puig MM (2005) Antiexudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. Eur J Pharmacol 511:207-217.
224. Rook JM, Hasan W, and McCarson KE (2008) Temporal effects of topical morphine application on cutaneous wound healing. Anesthesiology 109:130-136.
225. Roques BP (2000) Novel approaches to targeting neuropeptide systems. Trends Pharmacol Sci 21:475-483.
226. Rosseland LA (2005) No evidence for analgesic effect of intra-articular morphine after knee arthroscopy: a qualitative systematic review. Reg Anesth Pain Med 30:83-98.
227. Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, and Hargreaves KM (2009) Peripheral delta opioid receptors require priming for functional competence in vivo. Eur J Pharmacol 602:283-287.
228. Sacerdote P, Limiroli E, and Gaspani L (2003) Experimental evidence for immunomodulatory effects of opioids. Adv Exp Med Biol 521:106-116.
229. Sagar DR, Gaw AG, Okine BN, Woodhams SG, Wong A, Kendall DA, and Chapman V (2009) Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol Pain 5:59.
230. Sammarco JL, Conzemius MG, Perkowski SZ, Weinstein MJ, Gregor TP, and Smith GK (1996) Postoperative analgesia for stifle surgery: a comparison of intraarticular bupivacaine, morphine, or saline. Vet Surg 25:59-69.
231. Santos LC, de Moraes AN, and Saito ME (2009) Effects of intraarticular ropivacaine and morphine on lipopolysaccharide-induced synovitis in horses. Vet Anaesth Analg 36:280-286.
232. Sassani JW, Zagon IS, and McLaughlin PJ (2003) Opioid growth factor modulation of corneal epithelium: uppers and downers. Curr Eye Res 26:249-262.
233. Sawynok J (2003) Topical and peripherally acting analgesics. Pharmacol Rev 55:1-20.
234. Scanlin HL, Carroll EA, Jenkins VK, and Balkowiec A (2008) Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calciumdependent manner. Eur J Neurosci 27:2629-2642.
235. Schäfer M, Carter L, and Stein C (1994) Interleukin-1β and corticotropin-releasingfactor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219-4223.
236. Schafer M, Mousa SA, Zhang Q, Carter L, and Stein C (1996) Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 93:6096-6100.
237. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, Kieffer BL, and Basbaum AI (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148-1159.
238. Schmelz M and Paus R (2007) Opioids and the skin: "itchy" perspectives beyond analgesia and abuse. J Invest Dermatol 127:1287-1289.
239. Schmitt TK, Mousa SA, Brack A, Schmidt DK, Rittner HL, Welte M, Schäfer M, and Stein C (2003) Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology 98:195-202.
240. Scholz J and Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
241. Schramm CL and Honda CN (2010) Co-administration of delta- and mu-opioid receptor agonists promotes peripheral opioid receptor function. Pain 151:763-770.
242. Schütz J, Brandt W, Spetea M, Wurst K, Wunder G, and Schmidhammer H (2003) Synthesis of 6-amino acid substituted derivatives of the highly potent analgesic 14-O-methyloxymorphone. Helv Chim Acta 86:2142-2148.
243. Selley DE, Breivogel CS, and Childers SR (1993) Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 44:731-741.
244. Shannon HE and Lutz EA (2002) Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 42:253-261.
245. Shaqura MA, Zöllner C, Mousa SA, Stein C, and Schäfer M (2004) Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 308:712-718.
246. Sharp BM (2006) Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 20:9-14.
247. Simmons DL (2005) Anti-adhesion therapies. Curr Opin Pharmacol 5:398-404.
248. Sitte N, Busch M, Mousa SA, Labuz D, Rittner H, Gore C, Krause H, Stein C, and Schä fer M (2007) Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J Neuroimmunol 183:133-145.
249. Smith EM (2003) Opioid peptides in immune cells. Adv Exp Med Biol 521:51-68.
250. Smith EM, Morrill AC, Meyer WJ 3rd, and Blalock JE (1986) Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321:881-882.
251. Sorkin LS, Moore J, Boyle DL, Yang L, and Firestein GS (2003) Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol 184:162-168.
252. Spain JW, Roth BL, and Coscia CJ (1985) Differential ontogeny of multiple opioid receptors (mu, delta, and kappa). J Neurosci 5:584-588.
253. Ständer S, Gunzer M, Metze D, Luger T, and Steinhoff M (2002) Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 110:75-83.
254. Starowicz K, Nigam S, and Di Marzo V (2007) Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 114:13-33.
255. Stein A, Yassouridis A, Szopko C, Helmke K, and Stein C (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83:525-532.
256. Stein C (1993) Peripheral mechanisms of opioid analgesia. Anesthesia Analgesia 76:182-191.
257. Stein C (1995) The control of pain in peripheral tissue by opioids. N Engl J Med 332:1685-1690.
258. Stein C (2006) Intra-articular morphine for inflammatory pain. Reg Anesth Pain Med 31:496-497.
259. Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, and Spencer RH (2009) Peripheral mechanisms of pain and analgesia. Brain Res Rev 60:90-113.
260. Stein C, Comisel K, Haimerl E, Yassouridis A, Lehrberger K, Herz A, and Peter K (1991) Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 325:1123-1126.
261. Stein C, Gramsch C, and Herz A (1990a) Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci 10:1292-1298.
262. Stein C, Hassan AH, Lehrberger K, Giefing J, and Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342:321-324.
263. Stein C, Hassan AH, Przewłocki R, Gramsch C, Peter K, and Herz A (1990b) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87:5935-5939.
264. Stein C and Kopf A (2009) Anesthesia and treatment of chronic pain, in Miller's Anesthesia 7th Edition (Miller RD ed) pp 1797-1818, Churchill Livingstone, Philadelphia.
265. Stein C, Millan MJ, Shippenberg TS, Peter K, and Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269-1275.
266. Stein C, Pflüger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C, and Hassan AH (1996) No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 98:793-799.
267. Stein C, Schäfer M, and Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003-1008.
268. Stein C, Schäfer M, Cabot PJ, Carter L, Zhang Q, Zhou L, and Gasior M (1997) Peripheral opioid analgesia. Pain Rev 4:171-185.
269. Stephanou A, Knight RA, De Laurenzi V, Melino G, and Lightman SL (1991) Expression of pre-opiomelanocortin (POMC) mRNA in undifferentiated and in vitro differentiated human neuroblastoma cell lines. Prog Clin Biol Res 366:173-180.
270. Straub RH, Wolff C, Fassold A, Hofbauer R, Chover-Gonzalez A, Richards LJ, and Jessop DS (2008) Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheum 58:456-466.
271. Stremmel C, Horn C, Eder S, Dimmler A, and Lang W (2005) The impact of immunological parameters on the development of phantom pain after major amputation. Eur J Vasc Endovasc Surg 30:79-82.
272. Sung B, Loh HH, and Wei L (2000) Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury. Neurosci Lett 291:163-166.
273. Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, and Rogers TJ (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 99: 10276-10281.
274. Szabo I, Wetzel MA, and Rogers TJ (2001) Cell-density-regulated chemotactic esponsiveness of keratinocytes in vitro. J Invest Dermatol 117:1083-1090.
275. Takeba Y, Suzuki N, Kaneko A, Asai T, and Sakane T (2001) Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 28:2176-2183.
276. Takeda M, Tanimoto T, Ikeda M, Kadoi J, Nasu M, and Matsumoto S (2004) Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn. Neuroscience 125:995-1008.
277. Tanasescu R and Constantinescu CS (2010) Cannabinoids and the immune system: an overview. Immunobiology 215:588-597.
278. Tappe-Theodor A, Agarwal N, Katona I, Rubino T, Martini L, Swiercz J, Mackie K, Monyer H, Parolaro D, Whistler J, et al. (2007) A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 27:4165-4177.
279. Tedford HW and Zamponi GW (2006) Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 58:837-862.
280. Tegeder I and Geisslinger G (2004) Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev 56:351-369.
281. Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, and Lötsch J (2003) Peripheral opioid analgesia in experimental human pain models. Brain 126:1092-1102.
282. Terman GW, Shavit Y, Lewis JW, Cannon JT, and Liebeskind JC (1984) Intrinsic mechanisms of pain inhibition: activation by stress. Science 226:1270-1277.
283. Thacker MA, Clark AK, Marchand F, and McMahon SB (2007) Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105:838-847.
284. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B, Baird AN, Hanson RR, Wright JM, Lin HC, and Purohit RC (1996) Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Am J Vet Res 57:1080-1093.
285. Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, and Bianchi A (2001) Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21: 1104-1109.
286. Tokuyama S, Inoue M, Fuchigami T, and Ueda H (1998) Lack of tolerance in peripheral opioid analgesia in mice. Life Sci 62:1677-1681.
287. Truong W, Cheng C, Xu QG, Li XQ, and Zochodne DW (2003) Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 53:366-375.
288. Tulamo RM, Raekallio M, Taylor P, Johnson CB, and Salonen M (1996) Intraarticular morphine and saline injections induce release of large molecular weight proteoglycans into equine synovial fluid. Zentralbl Veterinarmed A 43:147-153.
289. Uc ̧eyler N, Schäfers M, and Sommer C (2009) Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196:67-78.
290. Uchida H, Ma L, and Ueda H (2010) Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci 30:4806-4814.
291. Valverde A and Gunkel CI (2005) Pain management in horses and farm animals. J Vet Emerg Crit Care 15:295-307.
292. van Dorp EL, Morariu A, and Dahan A (2008) Morphine-6-glucuronide: potency and safety compared with morphine. Expert Opin Pharmacother 9:1955-1961.
293. van Rijn RM, Whistler JL, and Waldhoer M (2010) Opioid-receptor-heteromerspecific trafficking and pharmacology. Curr Opin Pharmacol 10:73-79.
294. Varga K, Wagner JA, Bridgen DT, and Kunos G (1998) Platelet- and macrophagederived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035-1044.
295. Verma-Gandhu M, Bercik P, Motomura Y, Verdu EF, Khan WI, Blennerhassett PA, Wang L, El-Sharkawy RT, and Collins SM (2006) CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology 130:1721-1728.
296. Vetter I, Cheng W, Peiris M, Wyse BD, Roberts-Thomson SJ, Zheng J, Monteith GR, and Cabot PJ (2008) Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization. J Biol Chem 283:19540-19550.
297. Vetter I, Kapitzke D, Hermanussen S, Monteith GR, and Cabot PJ (2006) The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons. J Pain 7:488-499.
298. Vindrola O, Mayer AM, Citera G, Spitzer JA, and Espinoza LR (1994) Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalin-derived peptides induced by LPS in vivo. Neuropeptides 27: 235-244.
299. Wagner R, Janjigian M, and Myers RR (1998) Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 74:35-42.
300. Walczak JS, Pichette V, Leblond F, Desbiens K, and Beaulieu P (2005) Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 132:1093-1102.
301. Walczak JS, Pichette V, Leblond F, Desbiens K, and Beaulieu P (2006) Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes. J Neurosci Res 83:1310-1322.
302. Waldhoer M, Bartlett SE, and Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990.
303. Walker J, Catheline G, Guilbaud G, and Kayser V (1999) Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats. Pain 83: 509-516.
304. Walker JS (2003) Anti-inflammatory effects of opioids. Adv Exp Med Biol 521:148-160.
305. Walker JS, Scott C, Bush KA, and Kirkham BW (2000) Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat. Neuropeptides 34:193-202.
306. Wallace MS, Moulin D, Clark AJ, Wasserman R, Neale A, Morley-Forster P, Castaigne JP, and Teichman S (2006) A phase II, multicenter, randomized, doubleblind, placebo-controlled crossover study of CJC-1008-a long-acting, parenteral opioid analgesic-in the treatment of postherpetic neuralgia. J Opioid Manag 2:167-173.
307. Walwyn W, Evans CJ, and Hales TG (2007) Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons. J Neurosci 27:5092-5104.
308. Walwyn W, John S, Maga M, Evans CJ, and Hales TG (2009) Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol 76:134-143.
309. Walwyn W, Maidment NT, Sanders M, Evans CJ, Kieffer BL, and Hales TG (2005) Induction of delta opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons. Mol Pharmacol 68:1688-1698.
310. Wang HB, Zhao B, Zhong YQ, Li KC, Li ZY, Wang Q, Lu YJ, Zhang ZN, He SQ, Zheng HC, et al. (2010) Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci USA 107:13117-13122.
311. Watkins LR and Maier SF (2002) Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981-1011.
312. Wenk HN, Brederson JD, and Honda CN (2006) Morphine directly inhibits nociceptors in inflamed skin. J Neurophysiol 95:2083-2097.
313. Wenk HN and Honda CN (1999) Immunohistochemical localization of delta opioid receptors in peripheral tissues. J Comp Neurol 408:567-579.
314. Westly HJ, Kleiss AJ, Kelley KW, Wong PK, and Yuen PH (1986) Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 163: 1589-1593.
315. White FA and Miller RJ (2010) Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain. Brain Behav Immun 24:859-865.
316. Whiteside GT, Harrison JE, Pearson MS, Chen Z, Fundytus ME, Rotshteyn Y, Turchin PI, Pomonis JD, Mark L, Walker K, et al. (2004) DiPOA ([8-(3,3-diphenylpropyl)- 4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat. J Pharmacol Exp Ther 310:793-799.
317. Willer JC, Dehen H, and Cambier J (1981) Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212:689-691.
318. Wilson JL, Walker JS, Antoon JS, and Perry MA (1998) Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: inhibition by kappa-opioid agonist but not by NSAID. J Rheumatol 25:499-505.
319. Wolf NB, Küchler S, Radowski MR, Blaschke T, Kramer KD, Weindl G, Kleuser B, Haag R, and Schäfer-Korting M (2009) Influences of opioids and nanoparticles on in vitro wound healing models. Eur J Pharm Biopharm 73:34-42.
320. Woolf CJ and Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.
321. Wu ZZ, Cai YQ, and Pan HL (2009) A functional link between T-type calcium channels and mu-opioid receptor expression in adult primary sensory neurons. J Neurochem 109:867-878.
322. Yaksh TL (1988) Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 458:319-324.
323. Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, and Waldmann H (2002) Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 168:1069-1079.
324. Zhang N, Rogers TJ, Caterina M, and Oppenheim JJ (2004) Proinflammatory hemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol 173:594-599.
325. Zhang Q, Schäffer M, Elde R, and Stein C(1998a) Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 85:281-291.
326. Zhang X, Bao L, Shi TJ, Ju G, Elde R, and Hökfelt T (1998b) Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82:223-240.
327. Zhou L, Zhang Q, Stein C, and Schä fer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286:1000-1006.
328. Zhu Y, Hsu MS, and Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci 18:2538-2549.
329. Zöllner C, Mousa SA, Fischer O, Rittner HL, Shaqura M, Brack A, Shakibaei M, Binder W, Urban F, Stein C, et al. (2008) Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 118:1065-1073.
330. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, and Schafer M (2003) Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202-210.
331. Zöllner C and Stein C (2007) Opioids. Handb Exp Pharmacol (177):31-63.
332. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, and Högestätt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.